Benzodiazepine CGRP receptor antagonists

Details for Australian Patent Application No. 2004263080 (hide)

Owner Merck & Co., Inc.

Inventors Stump, Craig A.; Burgey, Christopher S.; Williams, Theresa M.

Agent Spruson & Ferguson

Pub. Number AU-B-2004263080

PCT Pub. Number WO2005/013894

Priority 60/482,854 26.06.03 US

Filing date 24 June 2004

Wipo publication date 17 February 2005

Acceptance publication date 18 December 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2005/013894 Priority application(s): WO2005/013894

18 December 2008 Application Accepted

  Published as AU-B-2004263080

23 April 2009 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the name of the Patentee from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263094-Programmed immune responses using a vaccination node

2004263079-Animal model for the analysis of tumor metastasis